Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Dublin, March 13, 2023 (GLOBE NEWSWIRE) -- The "Legal Services Pricing Platform" database has been added to ResearchAndMarkets.com's offering. The Platform takes the guesswork out of anonymized...
-
New York, US, March 13, 2023 (GLOBE NEWSWIRE) -- Maximize Market research, a global Material & Chemical market research firm, has published competitive intelligence and market research report on...
-
New York, March 13, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Satellite IoT Market by Service Type, Frequency Band, Organization Size, Vertical & Region -...
-
Covina, March 13, 2023 (GLOBE NEWSWIRE) -- “According to the latest research study, the demand of Desktop Virtualization Market accounted for US$ 12.3 billion in 2022 and is estimated to be US$ 35.2...
-
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, March 13, 2023 (GLOBE NEWSWIRE) -- Water Ways Technologies Inc. (TSXV: WWT) (FRA: WWT) ("Water Ways" or...
-
New York, US, March 13, 2023 (GLOBE NEWSWIRE) -- Maximize Market research, a global Material & Chemical market research firm, has published a competitive intelligence and market research report...
-
CAMBRIDGE, Mass., March 13, 2023 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying, developing and...
-
NEW YORK, March 13, 2023 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP, “Indaptus” or “the Company”), a biotechnology company focused on discovering and developing transformative...
-
New York, March 13, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Natural Vanillin Market by Source, Application And Region - Global Forecast to 2027" -...
-
SOUTH SAN FRANCISCO, Calif., March 13, 2023 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biopharmaceutical company focused on discovering and developing novel...